NIH Funding Freeze Halts Northwestern Cancer Research

The National Institutes of Health is the largest public funder of biomedical research in the world, but under the Trump administration, NIH is freezing funding to several universities, including Northwestern. One of the projects being delayed is cutting-edge research on ovarian and pancreatic cancer. Reset learns more about the effect of this freeze on patients and early career scientists with Josh Leonard, professor of chemical and biological engineering at Northwestern University. For a full archive of Reset interviews, head over to wbez.org/reset.